Basic Information
Basic information for SOX2-OT-287-14aa
Peptide Name SOX2-OT-287-14aa
Genome Position chr3:181741943-181741984[+]
Species Human
Peptide Sequence MHICYRIPVICRVF
Peptide Length 14
Unique No (SOX2-OT-207-14aa,SOX2-OT-218-14aa-1,SOX2-OT-225-14aa-2,SOX2-OT-234-14aa-2,SOX2-OT-276-14aa-1,SOX2-OT-283-14aa-2,SOX2-OT-285-14aa,SOX2-OT-291-14aa,SOX2-OT-292-14aa-1,SOX2-OT-293-14aa-2,SOX2-OT-294-14aa-1,SOX2-OT-295-14aa-1,SOX2-OT-296-14aa-1,SOX2-OT-297-14aa,SOX2-OT-298-14aa,SOX2-OT-299-14aa-1,SOX2-OT-303-14aa-1,SOX2-OT-304-14aa-1)
Grand Average of Hydropathicity 1.1786
Relative Molecular Mass 1984.41
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000242808;SOX2-OT
Transcript ID/Name ENST00000647034;SOX2-OT-287
Transcript Length 2920
Coding Ability 0.2702
DNA Sequence Corresponding to Peptide ATGCATATCTGTTACAGAATTCCTGTGATTTGTAGAGTTTTC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :